Kane Investment Management Inc. Sells 1,215 Shares of Lam Research Corporation $LRCX

Kane Investment Management Inc. decreased its position in shares of Lam Research Corporation (NASDAQ:LRCX) by 8.1% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 13,702 shares of the semiconductor company’s stock after selling 1,215 shares during the period. Kane Investment Management Inc.’s holdings in Lam Research were worth $1,339,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of the company. Grandfield & Dodd LLC purchased a new stake in shares of Lam Research during the second quarter worth about $258,000. King Wealth Management Group bought a new position in shares of Lam Research in the second quarter worth about $389,000. Banco Bilbao Vizcaya Argentaria S.A. boosted its holdings in shares of Lam Research by 21.7% in the second quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 172,525 shares of the semiconductor company’s stock valued at $16,792,000 after purchasing an additional 30,720 shares during the period. Sittner & Nelson LLC increased its stake in shares of Lam Research by 5.7% during the second quarter. Sittner & Nelson LLC now owns 3,595 shares of the semiconductor company’s stock valued at $350,000 after buying an additional 195 shares during the period. Finally, Fiera Capital Corp purchased a new position in Lam Research during the second quarter valued at approximately $9,214,000. 84.61% of the stock is currently owned by institutional investors.

Insider Transactions at Lam Research

In related news, Director Bethany Mayer sold 1,298 shares of the firm’s stock in a transaction that occurred on Monday, November 3rd. The shares were sold at an average price of $159.99, for a total value of $207,667.02. Following the transaction, the director owned 1,652 shares in the company, valued at approximately $264,303.48. This trade represents a 44.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP Vahid Vahedi sold 52,190 shares of the firm’s stock in a transaction on Monday, October 13th. The shares were sold at an average price of $138.90, for a total transaction of $7,249,191.00. Following the completion of the transaction, the senior vice president directly owned 251,047 shares in the company, valued at approximately $34,870,428.30. This represents a 17.21% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 62,528 shares of company stock valued at $8,880,448 over the last three months. 0.31% of the stock is currently owned by insiders.

Lam Research Price Performance

Shares of LRCX opened at $148.26 on Friday. The company has a current ratio of 2.21, a quick ratio of 1.60 and a debt-to-equity ratio of 0.37. Lam Research Corporation has a twelve month low of $56.32 and a twelve month high of $167.15. The firm has a market capitalization of $186.22 billion, a PE ratio of 32.66, a P/E/G ratio of 1.68 and a beta of 1.87. The stock’s 50 day moving average is $140.75 and its two-hundred day moving average is $109.40.

Lam Research (NASDAQ:LRCX) last released its quarterly earnings data on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.22 by $0.04. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The firm had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.23 billion. During the same quarter in the prior year, the business posted $0.86 earnings per share. Lam Research’s revenue was up 27.7% compared to the same quarter last year. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Research analysts anticipate that Lam Research Corporation will post 3.71 earnings per share for the current year.

Lam Research Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 7th. Stockholders of record on Wednesday, December 3rd will be given a $0.26 dividend. The ex-dividend date is Wednesday, December 3rd. This represents a $1.04 annualized dividend and a dividend yield of 0.7%. Lam Research’s dividend payout ratio is currently 22.91%.

Analyst Upgrades and Downgrades

LRCX has been the subject of several research analyst reports. Zacks Research raised shares of Lam Research from a “hold” rating to a “strong-buy” rating in a research report on Monday, October 20th. Raymond James Financial increased their price target on Lam Research from $90.00 to $110.00 and gave the company an “outperform” rating in a report on Thursday, July 31st. The Goldman Sachs Group boosted their price objective on shares of Lam Research from $115.00 to $160.00 and gave the company a “buy” rating in a report on Wednesday, October 8th. Evercore ISI raised their price objective on shares of Lam Research from $115.00 to $170.00 and gave the company an “outperform” rating in a research note on Thursday, October 23rd. Finally, JPMorgan Chase & Co. increased their price objective on shares of Lam Research from $113.00 to $165.00 and gave the company an “overweight” rating in a research report on Thursday, October 23rd. One investment analyst has rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $149.04.

About Lam Research

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.